These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8664207)

  • 1. Effects of naltrexone on mannerisms and water imbalance in polydipsic schizophrenics: a pilot study.
    Becker JA; Goldman MB; Alam MY; Luchins DJ
    Schizophr Res; 1995 Nov; 17(3):279-82. PubMed ID: 8664207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic role of naltrexone in negative symptom schizophrenia.
    Marchesi GF; Santone G; Cotani P; Giordano A; Chelli F
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1239-49. PubMed ID: 8868206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of nalmefene augmentation in neuroleptic-stabilized schizophrenic patients.
    Rapaport MH; Wolkowitz O; Kelsoe JR; Pato C; Konicki PE; Pickar D
    Neuropsychopharmacology; 1993 Sep; 9(2):111-5. PubMed ID: 8105790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine treatment in polydipsia and intermittent hyponatremia.
    Spears NM; Leadbetter RA; Shutty MS
    J Clin Psychiatry; 1996 Mar; 57(3):123-8. PubMed ID: 8617697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrolyte-balanced sports drink for polydipsia-hyponatremia in schizophrenia.
    Quitkin FM; Garakani A; Kelly KE
    Am J Psychiatry; 2003 Feb; 160(2):385-6. PubMed ID: 12562594
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial.
    Tek C; Guloksuz S; Srihari VH; Reutenauer EL
    BMC Psychiatry; 2013 Jun; 13():176. PubMed ID: 23805859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone augmentation of neuroleptics in schizophrenia.
    Sernyak MJ; Glazer WM; Heninger GR; Charney DS; Woods SW; Petrakis IL; Krystal JH; Price LH
    J Clin Psychopharmacol; 1998 Jun; 18(3):248-51. PubMed ID: 9617985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine restores water balance in schizophrenic patients with polydipsia-hyponatremia syndrome.
    Canuso CM; Goldman MB
    J Neuropsychiatry Clin Neurosci; 1999; 11(1):86-90. PubMed ID: 9990561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of olanzapine on polydipsia and intermittent hyponatremia.
    Littrell KH; Johnson CG; Littrell SH; Peabody CD
    J Clin Psychiatry; 1997 Dec; 58(12):549. PubMed ID: 9448660
    [No Abstract]   [Full Text] [Related]  

  • 10. Diminished glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients.
    Goldman MB; Wood G; Goldman MB; Gavin M; Paul S; Zaheer S; Fayyaz G; Pilla RS
    J Clin Endocrinol Metab; 2007 Feb; 92(2):698-704. PubMed ID: 17118992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of risperidone on polydipsia and hyponatremia in schizophrenia.
    Landry P
    Can J Psychiatry; 1995 Nov; 40(9):566-7. PubMed ID: 8574992
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjunctive quetiapine treatment of the polydipsia, intermittent hyponatremia, and psychosis syndrome: a case report.
    Montgomery JH; Tekell JL
    J Clin Psychiatry; 2003 Mar; 64(3):339-41. PubMed ID: 12716283
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled pilot study of naltrexone to counteract antipsychotic-associated weight gain: proof of concept.
    Tek C; Ratliff J; Reutenauer E; Ganguli R; O'Malley SS
    J Clin Psychopharmacol; 2014 Oct; 34(5):608-12. PubMed ID: 25102328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicated chronic schizophrenic patients do not demonstrate left turning asymmetry.
    Levine J; Martine T; Feraro R; Kimhi R; Bracha HS
    Neuropsychobiology; 1997; 36(1):22-4. PubMed ID: 9211440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective treatment of pruritus with naltrexone, an orally active opiate antagonist.
    Metze D; Reimann S; Luger TA
    Ann N Y Acad Sci; 1999 Oct; 885():430-2. PubMed ID: 10816681
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of polydipsia on water excretion in hyponatremic, polydipsic, schizophrenic patients.
    Goldman MB; Robertson GL; Luchins DJ; Hedeker D
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1465-70. PubMed ID: 8636352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Limited role of naltrexone in the treatment of opiate addiction].
    van Brussel GH
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with captopril of an elderly man with polydipsia and hyponatremia.
    Tueth MJ; Broderick-Cantwell J
    J Geriatr Psychiatry Neurol; 1993; 6(2):112-4. PubMed ID: 8512627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia.
    Petrakis IL; O'Malley S; Rounsaville B; Poling J; McHugh-Strong C; Krystal JH;
    Psychopharmacology (Berl); 2004 Mar; 172(3):291-7. PubMed ID: 14634716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
    Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
    J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.